The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Statins-Global Market Insights and Sales Trends 2024
Synopsis
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body.
The global Statins market size is expected to reach US$ 16430 million by 2029, growing at a CAGR of 1.8% from 2023 to 2029. The market is mainly driven by the significant applications of Statins in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Statins market. Astrovastatin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fluvastatin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Statins, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Statins market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Statins market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Statins sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Statins covered in this report include AstraZeneca, Pfizer, GlaxoSmithKline, Novartis International, Merck, Biocon, Concord Biotech and Aurobindo Pharma, etc.
The global Statins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Pfizer
GlaxoSmithKline
Novartis International
Merck
Biocon
Concord Biotech
Aurobindo Pharma
Global Statins market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Statins market, Segment by Type:
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Global Statins market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Statins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Statins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Statins are special class of drugs that helps in lowering of blood cholesterol level in the body.
The global Statins market size is expected to reach US$ 16430 million by 2029, growing at a CAGR of 1.8% from 2023 to 2029. The market is mainly driven by the significant applications of Statins in various end use industries. The expanding demands from the Hospitals and Clinics, are propelling Statins market. Astrovastatin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Fluvastatin segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Statins, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Statins market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Statins market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Statins sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Statins covered in this report include AstraZeneca, Pfizer, GlaxoSmithKline, Novartis International, Merck, Biocon, Concord Biotech and Aurobindo Pharma, etc.
The global Statins market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AstraZeneca
Pfizer
GlaxoSmithKline
Novartis International
Merck
Biocon
Concord Biotech
Aurobindo Pharma
Global Statins market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Statins market, Segment by Type:
Astrovastatin
Fluvastatin
Lovastatin
Pravastatin
Simvastatin
Others
Global Statins market, by Application
Hospitals
Clinics
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Statins manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Statins in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Statins Market Overview
1.1 Statins Product Overview
1.2 Statins Market Segment by Type
1.2.1 Astrovastatin
1.2.2 Fluvastatin
1.2.3 Lovastatin
1.2.4 Pravastatin
1.2.5 Simvastatin
1.2.6 Others
1.3 Global Statins Market Size by Type
1.3.1 Global Statins Market Size Overview by Type (2018-2029)
1.3.2 Global Statins Historic Market Size Review by Type (2018-2023)
1.3.3 Global Statins Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Statins Sales Breakdown by Type (2018-2023)
1.4.2 Europe Statins Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Statins Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Statins Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Statins Sales Breakdown by Type (2018-2023)
2 Global Statins Market Competition by Company
2.1 Global Top Players by Statins Sales (2018-2023)
2.2 Global Top Players by Statins Revenue (2018-2023)
2.3 Global Top Players by Statins Price (2018-2023)
2.4 Global Top Manufacturers Statins Manufacturing Base Distribution, Sales Area, Product Type
2.5 Statins Market Competitive Situation and Trends
2.5.1 Statins Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Statins Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Statins as of 2022)
2.7 Date of Key Manufacturers Enter into Statins Market
2.8 Key Manufacturers Statins Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Statins Status and Outlook by Region
3.1 Global Statins Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Statins Historic Market Size by Region
3.2.1 Global Statins Sales in Volume by Region (2018-2023)
3.2.2 Global Statins Sales in Value by Region (2018-2023)
3.2.3 Global Statins Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Statins Forecasted Market Size by Region
3.3.1 Global Statins Sales in Volume by Region (2024-2029)
3.3.2 Global Statins Sales in Value by Region (2024-2029)
3.3.3 Global Statins Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Statins by Application
4.1 Statins Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.2 Global Statins Market Size by Application
4.2.1 Global Statins Market Size Overview by Application (2018-2029)
4.2.2 Global Statins Historic Market Size Review by Application (2018-2023)
4.2.3 Global Statins Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Statins Sales Breakdown by Application (2018-2023)
4.3.2 Europe Statins Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Statins Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Statins Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Statins Sales Breakdown by Application (2018-2023)
5 North America Statins by Country
5.1 North America Statins Historic Market Size by Country
5.1.1 North America Statins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Statins Sales in Volume by Country (2018-2023)
5.1.3 North America Statins Sales in Value by Country (2018-2023)
5.2 North America Statins Forecasted Market Size by Country
5.2.1 North America Statins Sales in Volume by Country (2024-2029)
5.2.2 North America Statins Sales in Value by Country (2024-2029)
6 Europe Statins by Country
6.1 Europe Statins Historic Market Size by Country
6.1.1 Europe Statins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Statins Sales in Volume by Country (2018-2023)
6.1.3 Europe Statins Sales in Value by Country (2018-2023)
6.2 Europe Statins Forecasted Market Size by Country
6.2.1 Europe Statins Sales in Volume by Country (2024-2029)
6.2.2 Europe Statins Sales in Value by Country (2024-2029)
7 Asia-Pacific Statins by Region
7.1 Asia-Pacific Statins Historic Market Size by Region
7.1.1 Asia-Pacific Statins Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Statins Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Statins Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Statins Forecasted Market Size by Region
7.2.1 Asia-Pacific Statins Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Statins Sales in Value by Region (2024-2029)
8 Latin America Statins by Country
8.1 Latin America Statins Historic Market Size by Country
8.1.1 Latin America Statins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Statins Sales in Volume by Country (2018-2023)
8.1.3 Latin America Statins Sales in Value by Country (2018-2023)
8.2 Latin America Statins Forecasted Market Size by Country
8.2.1 Latin America Statins Sales in Volume by Country (2024-2029)
8.2.2 Latin America Statins Sales in Value by Country (2024-2029)
9 Middle East and Africa Statins by Country
9.1 Middle East and Africa Statins Historic Market Size by Country
9.1.1 Middle East and Africa Statins Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Statins Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Statins Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Statins Forecasted Market Size by Country
9.2.1 Middle East and Africa Statins Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Statins Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AstraZeneca
10.1.1 AstraZeneca Company Information
10.1.2 AstraZeneca Introduction and Business Overview
10.1.3 AstraZeneca Statins Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AstraZeneca Statins Products Offered
10.1.5 AstraZeneca Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Statins Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Pfizer Statins Products Offered
10.2.5 Pfizer Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline Statins Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GlaxoSmithKline Statins Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Novartis International
10.4.1 Novartis International Company Information
10.4.2 Novartis International Introduction and Business Overview
10.4.3 Novartis International Statins Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis International Statins Products Offered
10.4.5 Novartis International Recent Development
10.5 Merck
10.5.1 Merck Company Information
10.5.2 Merck Introduction and Business Overview
10.5.3 Merck Statins Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Merck Statins Products Offered
10.5.5 Merck Recent Development
10.6 Biocon
10.6.1 Biocon Company Information
10.6.2 Biocon Introduction and Business Overview
10.6.3 Biocon Statins Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Biocon Statins Products Offered
10.6.5 Biocon Recent Development
10.7 Concord Biotech
10.7.1 Concord Biotech Company Information
10.7.2 Concord Biotech Introduction and Business Overview
10.7.3 Concord Biotech Statins Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Concord Biotech Statins Products Offered
10.7.5 Concord Biotech Recent Development
10.8 Aurobindo Pharma
10.8.1 Aurobindo Pharma Company Information
10.8.2 Aurobindo Pharma Introduction and Business Overview
10.8.3 Aurobindo Pharma Statins Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Aurobindo Pharma Statins Products Offered
10.8.5 Aurobindo Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Statins Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Statins Industrial Chain Analysis
11.4 Statins Market Dynamics
11.4.1 Statins Industry Trends
11.4.2 Statins Market Drivers
11.4.3 Statins Market Challenges
11.4.4 Statins Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Statins Distributors
12.3 Statins Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
